BSPM - Biostar Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1600
-0.1200 (-42.86%)
At close: 9:30AM EDT
Stock chart is not supported by your current browser
Previous Close0.2800
Open0.1600
BidN/A x N/A
AskN/A x N/A
Day's Range0.1600 - 0.1600
52 Week Range0.1300 - 3.4700
Volume143
Avg. Volume1,111
Market Cap421,950
Beta (3Y Monthly)3.66
PE Ratio (TTM)0.47
EPS (TTM)0.3400
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIRElast year

    Today's Research Reports on Stocks to Watch: Biostar Pharmaceuticals and ABIOMED

    NEW YORK, NY / ACCESSWIRE / July 27, 2018 / Biostar shares saw a rebound on Thursday, closing the day up over 27% after falling on Wednesday when Wall Street learned the company had received a delisting ...

  • ACCESSWIRElast year

    Biostar Pharmaceuticals Received Nasdaq Delisting Notification

    XIANYANG, CHINA / ACCESSWIRE / July 25, 2018 / Biostar Pharmaceuticals, Inc. (BSPM) (''the Company''), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on July 19, 2018 it received a notification letter from Nasdaq Listing Qualifications (''Nasdaq'') advising the Company that following review of the Company's plan of compliance, the Nasdaq staff determined to delist the Company's common stock from the Nasdaq Capital Market. The delisting notification stated that such delisting would be effective at the opening of business on July 30, 2018 unless the Company requests an appeal of the delisting determination. As previously disclosed, the Company was cited for failures to comply with this Listing Rule because it had not filed its Form 10-K for the year ended December 31, 2017 and its Form 10-Q for the period ended March 31, 2018.

  • We're sorry this is all we were able to find about this topic.